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~ A New Percutaneous Vascular Surgical Devlce 
After PTCA and 8tenting 
Winfded Haerer, Ralph 8chulze, Bernd Ludwig. Dr Haemr Hospital, U/m, 
Germany 
The femoral artery is the most common vessel access for inte~ventional 
pmceduras. Local problems am frequent by using larger devices or strong 
anticoa0ulation protocols after stenting. Therefore we used the new single 
c~gerator percutaueous vascular surg.~al device (Perdoss) in a prospective 
•al. The new 9 F-dovlee has a sheath which houses four sutured needles. 
The knom are made outside and are advanced by a special knot pusher to 
the arlenJ surface. 
A consecutive uehes of 350 patients (pts) was included. PTCA, atheree- 
tomy or stont deployment was done by use of 8 or 9 F guiding catheters. A 
successful stont implantation was carded out in 320 pts of this series. In these 
cases the surgical dolce was employed immediato,~y after the Intetventional 
procedure and them was no need for a withdrawal of hepadn. The patients 
had to stay in bed for only 4 hours with a mild compression bandage and 
were aliowed to walk after this period. 
The results were as follows: Procedural success 322/3~ pls (92%), false 
anemysm 0/322 pts, haemota (over 5 cm) 0/322 pts, vees~; !hmmhosts 0/322 
pts. Compression of the artery (up to 1 hour) was done in Ihe remaining 38 
pts followed by a light compression bandage (1 aneuWsm). Before use of 
the ne#v device our local complications were 1% false a~eurysm or bleeding 
with surgical repair and 8% severe heematoma. 
The new percutaneous vascular surgical device reduces local complice- 
tlona. AnScoagula~on protocols can be administered unchanged and there- 
fore the results of complex angioplasty can be optimized. 
~ T h e " D a r k  Overly Aggressive Side" of Muk'ldevice 
Athemctomy 
Gaston R. Dussaillant, Gary S. Mintz, Augusto O. Ploha~, Kenno~ 
M. Kent, lowell F. Satier, Jeffrey J. Popma, Theresa Bucher, Carol Walsh, 
Paul Mackel, Regina Deible, Bridget Golden, Martin B. Leon. Washington 
Hospital Center, Washington, DC 
Adjunctive DCA follewh~g mlationa} atherectomy (RA) results in a larger fu- 
men than stand-alone RA or RA+ad]uective PTCA. To assess the iongterm 
Mects of this strategy, we folkn~ed 183 pts treated wi~ RA+ad~mc~e DCA 
and imaged using intravascular ullraseund. Pra- and post - imer~n a~te- 
dal, lumen, and plaque areas (mn~ were used to calculate plaque humeri 
(plaque/mleflal reas) and the contribution of tissue removal to lumen en- 
largement (atheractomy index = Aplaque/Alumen areas). After 11.8 4- 4.5 
mos, 38 pts (23%) required ta,'gof lesion revascularization (TLR): 
No TLR "R.R p 
Pm-intenmntlon artedat area 18.1 ±5.3 18.74-4.3 0.669 
I.umen area 1.9~ 1.0 1.7d:0.8 0.522 
Plaque area 16.24-5.1 17.04-4.4 0.491 
Post~t lon  artedal area 20.7 4. 5.9 19.6 4. 5.1 0.377 
~ama 6.8:1:2.1 8.04-18 0.049 
Plaque 8ma 13.84-4.9 13.74-4.8 0.g02 
Raque bumen (%) 664.8.7 694- 0.0 0.103 
~ Imbx (%) 88±25 844-~ o.e¢~ 
Reference lumen area and total and supedlclal arcs of lesion calcium 
were similar. Nthough post-intervention lumens were sllghtty Sheller (6.0 
vs 6.8 mm~), the atherec~omy irWex was gdkingly greater (84 vs 59%) in 
10is requiring TLR. We conc/ude that the strategy of RA+DCA results in 
favorable Iongterm pt outcomes (TLR = 23%). However, pts requiring TLR 
had more aggressive tissue removal (higher atherecfomy Index) suggesting 
t~t  exaggerated eep vessel wall injury may be do~edous. 
~ Reduced Antlcoagulstion Stesting Protocol for 
(RAPS) in Smaller Coronary Vessels Using 
fntravascuiar UIb'asound Guidance. 30 Day 
~ura l  Results 
David K. Roberts, AnM Arthur, Raye L Bellinger, James E. Lewis, Shenjl 
I. Haas, Carol A. Pariss. Sulter Instilute for Medical Research, and U.C, 
Oa',#s Affiliated Hospitals, Sacramento, CA 
Although coronary stenting (S) of smaller < 3 mm vessels (SCV) was initially 
fdonlffled as a risk racer for stent lhmmbosis, STRESS enrolled a signlflcout 
number of SCV with acceptable results. We report he initial 30 day results 
Of RAPS in SCV. 43 patients with 57 lesions in 2.5-,3.0 nun native coro- 
nary vessels underwent stentle9 using 79 Palmaz-Schetz coronmy stem. 
Lesion indications were 51 (89.5%) de novo P._-x~ive, 1 (1.8%) restenottc, 
and 5 (8.7%) suboptimal results or threatened closures following balloon 
angioplasly or athe~¢tomy. Clinical [mese~a~on was 23 (53.4%) unstable 
angina, 14 (32.6%) stabla angina, and £ (14.0%) < 72 hours 8/P MI. Follow- 
ing intravascular ultrasound (WUS), final stent deployment was performed at 
16.08 =I: 0.62 atmospheres. All stonts had a lloal cross-seclional area (CSA) 
>_ 80% of reference vessel CSA, and wee treated with aspidn 325 mg and 
tk~ina  '300 mg daily for one month, and enoxapadn 60 mg daily for three 
weeks. IVUS Results 
Reference vessel (:S'A mm 6.65 ± 0.31 
Refemnoe Vessel MLD mm 2.5 :b 0.07 
Vessel MaJofR~mor Axis Ratio 0.78 ± 0.02 
Reference Stent CSA mm 7.56:1:0.40 
Reference ~ent MID mm 2.71 =t: 0.09 
Stent Minor/Maim Axis 0.80 ± 0.02 
Mean % CSA b"t'erd ~enods -13.7 4. 0.04% 
Mean % MI.D Stent S1enosis --8.4 + 0.03% 
There were no RAPSprocedural complica~ons ofdeath, MI, or emergency 
CABG. Thee were no s ign~ bleeding ¢omplicaliona requiting blood 
b-ansfusion. 1 patient developed a femoral pseudoaneurysm that resolved 
with compression. There were no stent acute ~'~ subacute th in - - i s .  
In condus/on: Coronary stent~ng Of smaller vessels with intmvascolm, u~'a- 
sound guidance for high pressure gent deployment can be pedormed safely 
with excellent one month procedural resufls usin~ a reduced anticoagulation 
regimen. 
Myocarditts: Insights Into Cause and 
Treatment 
Wednesday, March 27, 1996, 3:00 p.m.-5:00 p.m. 
Orange County Convention Center, Hall E 
Presentation Hour: 3:00 p.m.--4:00 p.m. 
~"~- '~ foh ib~ of  Imlucibfe Nitric Oxide Synlhase 
Reduces Myocardial Injury in Autolmmune 
Myocardms Ram 
Michiaki Hiroe, Shiperu Ishlyama, Toshio Nlsh~awa, Hime Nakazawa, 
Hireshi Ito, Takashi Shimojo, Takeshi Kasajima, Fumiaki Marureo. Tokyo 
Medical and Dental Univemity, Tokyo Women~ Medical Co#eoe, Tokai 
Un~s~,  Japan 
We have previously demonstrated the expression of inducible Nlaic Oxide 
Syuthese (~OS) and perexyn~e in impaired myocam~ c~ ~ong with 
increased nitrite f o ~  and 02- radical pnxJt¢~n in autoimmune my- 
ocerd~s rets, suggesting that NO modu~tes myocard~J (bmago h~ this my- 
ocamle;, in the prasent study, we investigated ~ aminogttanidine(AG), 
a selec~ve inhibitor of iNOS, modulates the inflammatory oSsorder of my- 
ocarcli'ds. Lewis rats were sens~ to develop myocarditts with an injection 
of porcine myosin. AG (400 mg/kg per day) was intraperitoneally admin- 
istered to ~s  every ~ay from the day pdor to the flint immunization with 
myosin. Hearts v,em removed for examkzalJon on day 21. Blood samples 
were simultaneously taken from the heart cavity. The severity of myocarcli- 
tls was assessed by measudng the h~11x)fogic~ly alfected % area and 
serem CIr. MB le~ele. Serum NOx levels were alse meastm~l, l~an % area 
of ioflansn~tow lesions and CK-MB levela were s ign i f i~  decreased in 
the rats with ~ given AG. 
NOxlmM) CK-Malngtrn~) Area('/,} 
Myosin conlml (n - 10) 784-12 1024-16 .r,R ~ 13 
"P < 0,01,"P < 0.0(]1 
Conclusions: AG Inh~dds the extension Of n ' ~  InJt.w in ;'n',;ocaxo~is 
by s~l:.~-~lg NO overpreducl~n. AG may be an effective drug for the 
Ueatment of myocami,s. 
• '"  Cell Infiltration tn the Subacute Phase ow 
Myocerdms 
Yasushl Abe, Jiy~ng Klm, Masatake Fukunaml, Masaham Ohmork 
Tsuyeshi Shimonagata, Kazuaki Kumagak Takahisa Yan~da, Motoo Dat., 
Syo~ Sanada, Nodtske Hofd. D/vfs/on of ~ .  Osaka Prafeofur'~ 
Hes~ta/, Os,~,~ Japan 
The leflammatory cell infillz-ation i  the subacute phase of acute mycoan~is 
might detsdorate the recovery of left venlficol~LV) function through factors 
such as c '~ .  To elucidate whether myo~t  inflammatory cells in- 
lIIIralion in the subacute phase Of myocaldltis i rd l~  the Ixognosis of 
loft ventdcolar funotion, we sfudiod 16 pts with acoto ~ ~ 















394A ABSTRACTS-Poster JACC February 1996 
LV in the subecute phase(1 --6 months after the onset of myocardifis), and In- 
flammato.ry calls(LCA cells) identified with immusoporoxidase staining using 
anti-leakocyto common antigen serum ware counted In high power field of 
all samples. The LV end diastolic dimenalon(LVDd) and ejeCtion fractlen(EF) 
ware measured by the ech~hy at the biopsy(B) and one year 
lats.,(F). There was a significant correlation botwean the mean number of 
LCA positive cells and the %chasge of LVDd (r = 0.551, p < 0.05). 16 pts 
were classified by the average number of LCA cells into Group-I(n = 7) with 
1.0 or mom(/HPF) LCA coils and Gmup-II(n = 9) with LCA cells lass than 
1.0/HPR The results wore as shown below. 
LCAOegs(/HPF) B-LVDdimm)/EF F-LVDd(mn)/1EF 
Gmup-I 2.6 + 0.8 57.5.4.5.1/0.53-1-0.09 57.6 d= 5.6/0.51 :l: 0.12 
Group-!l 0.6 =b 0.2 55.1 4- 5.3/0.51 d: 0.08 50.8:1:6.4*/0.59 =E 0.08 
*p < 0.05 vs Gmup-I 
There was no significant difference in the period from the onset of my- 
ocaidifis to the biopsy (Group-I vs Gmup.ll; 3.0 d: 1.9 ve 1.9 + 1.6 months). 
LVDd decreased in GroulPII 1 year after biopsy mere than in Group-I. Thus, 
these results indicate that the improvement of cardiac lunCticn in acute my- 
ocarditis might be predictsd by (he degree of residual LCA infiilration in 
subacute phase(over one month after the onset). 
~ '~-~ Cimulating Cardiac Autoantibodles as 
Autolmmune Markers in Clinical and 
Biopsy-Proven Myocardltls 
Allda L.R Catorlo, Alan J. Haven, Jonathan H. Goldman, Luciano Dalla 
Ubora, Kamran M. Baig, William J. McKenna. Depts of Cardiology, F__xp 
Biomed Sci, Universily of Padua, Padua, Italy; Dept of Cardiolngical 
Sciences, St George's Hospital, London, United Kingdom 
Myosardifis and dilated cardiomyopathy (DCM) may be phases of an ongo- 
log autoimmune disease of the myocardium. Cardiac autoantibsdics (Abs) 
are found in 30-40% of DGM patients. Their detection In myoca~dis would 
provide evioence for autoimmunily. Cardiac antibody status was assessed 
in 53 patients from the MyocaMifis Treatment Tdal (35 male, aged 42 d: 15 
years). The antibody speaificifiss included organ-specific and skeletal mus- 
cle croas-raactlve Aba by indirect immunofluorescerme and anti-a myosin 
Abe by enzyme-linked immunssorbsnt assay (ELISA). All patients had clin- 
ical myocardifis and unexplained heart failure, but only 24 ware classified 
as histological myocarditis (Dallas cdtoda) on endomyocam'ial biopsy and 
rsndomised in ~m TdaL By Immunsfluorescenca rdiac ~ were more 
common in myocardifis patients than in nommis (13/53, 24°/, ve 18/200, 
9%, p = 0.004); by ELIGA abnormally raised anti-a myosin Abe ware also 
more frequent han in eormals (9/53, 17% ve 1/52, 2%, p = 0.009); 18 pa- 
tients (34%) had a positive result with one or both tests. Similar proportions 
of patients with and without histological myoca~itis eorifalned Abe by im- 
musofluoreacence (8/24 vs 5/29 respectively, p = NS) and by ELISA (4/24 
ve 5/29 respectively, p = NS). Cardiac Abe are found in 34% of patients with 
clinical myocardifis; this provides evidence for autoimmune involvement. The 
lack of correlation of antibody status with the histological diagnosis of my- 
ocardifis uggests that there may be inaccuracy when diagnosis is made on 
histology alone. Autoimmune markers may provide adjunct diagnostic tools 
and Identify myocarditis patients in whom Immunosupproasicn is of potsntial 
benefit. 
Preliminary Report of the Multicenter Giant Cell 
Myoeardit is Study Group 
Leslie 1". Cooper, Gerald J. Berry, Ralph ShebotaL San Diego Veterans 
Affaim Medical Center, and University of Ca//fomla San D/ego, San D/ego, 
CA 
idiopathic Giant Cell Myocardifis is a rare and frequently fatal disease of 
unknown causo which has only been reported in isolated cases and two 
small sades. Accordingly, research on this disease Is hampered by a lack 
of data. In January 1995, we established a muificenter study group to bel- 
tsr address the many unresolved questions about the natural history and 
~rea~lant of Idiopathfc giant cell myocarddts. Direct mailing to cardiovascular 
centers worldwide and journal announcements produced 42 cases ranging 
in age from 39 days to 70 years. Most present with congestive head failure or 
ventdcuisr dyerbythmias. Without immunesUlNxeealon the clinical course is 
one of rapid detodoretion to death or heart transplant. Several patients ur- 
vived Iongtorm (range 3-9 yrs) after immunosuppresalve treatment Thirteen 
patients in our registry underwent heart transplant. Eleven are alive up to 12 
years peat - t in - - t ,  2 wfth histoicglc disease recurrence. This is by far the 
largest cohort of this rare disease ever reported and represents the celleothm 
expedenca of many medical centers waddwide. We hope to present a final 
report at future sclentitic sessions. 
• Arrhythmogenic Right Ventdcular 
Dyspbsla.Cerdiomyopathy:  A Form of  Healing 
I~ocard~is?  
Allen Burke, Andrew Fad), Reau VirmanL Armed Forces Institute of 
Pathology, Washington, D.C. 
To detormir~e the role of inflammation and fibrosis in dght ventdcutsr dysplasia 
(RVD), we histologically evaluated 15 hearts from patients with RVD dying 
suddenly, and 11 age-matchnd control hearts. RVD was defined as right 
ventdcular dilatatior tMth focal fibrosis or thinning < 0.5 ram. Eight histologio 
sections were taken L~om each ventricle, apex to base, stained for collagen, 
and the degree of fat infiltration, fibrosis, and number of Inflammatory foci 
quantitated. The mean age of RVD was 31 ~ 10 years. 4 cases (27%) 
ware familial, 6 patients had a history of arrhythmtas (40%), and 8 deaths 
occuned dudng exercise (53%). Focl of Inflammation ware present in 14/15 
cases (93%)(mean umber 15 4. 5.2), and microscopic foci of left ventricufar 
fibrosis and/or inf~mmation were found (n 12 cesea (83%). Inflammation 
correlated negatively with age of the patient CO = 0.02, r ~ 0.4), and fibrosis 
showed a positive correlalisn with age (p = 0.008, t 2 0.5). Left ventdcuisr 
fibrosis was greatest in the base of the free wall (12 d: 3%) and least in 
the ventdcuisr septum (6.6 =1: 0.9%, p = 0.03). Fibrosis was diffuse in the 
right ventricle (mean 20 -I- 5%) without predilection for site. No d~erences 
in the degree of fibrosis or inflammation were noted with respect to family 
history, exercise at death, or history of arrhythmias. Compared to controls, 
RVD was hearts had greater fibrosis (p = 0.001) and inflammation (p = 
0.0001), but there was no significant difference In degree of fat infiltration of 
the dght ventricle (34 4- 4.8% RVD vs. 23 • 5.6% control, p = 0.1). RVD is 
as inflammatory disease that progresses to fibrosis and often involves both 
ventricles; fat infiltration is a secondary phenomenon. 
~ Arrhythmogenic Right Ventdcuiar 
Cardiomyopothy: DyspiaMa, Dystrophy or  
Myocardigs? 
Cdstina Basso, Domenico Corrado, Madaluisa Valento, Armalisa Aagelini, 
Andrea Nava, Gaetano Thiene. University of Padua,/tat'/ 
Aim of the investigation was to elucidate the nature of the pathobldiogical 
events underlying amhythmoganic right venthcolar cord io~ (ARVC). 
30 hearts with ARVC ware studied (20 M, 10 R aged 15-65 years, mean 
28). Source of specimens was autopsy in 27 and cardiac t~,-~splantation in 
3. Mede of death of autopsy casas was sadden In 34 ead congeative heart 
failure in 3 (due to cerebral thromboembolisro in 1). Previous symptoms 
in terms of syncope, palpitations or heart faiibre, m complained by 17 
patients (57%). Basal ECG, available in 19, showed inverted T-wavas In the 
right precorclial leads in 15 (79%) and venldcular anbythmias in 15 (79%). 
RV aneurysms were present in 15 hearts (50%), mostly located in the infodor 
wall. Involvement o! the left ventricle was observed in 14 cases (47%) and 
in 6 of them was extended to the ventdcutar septum. S~lttored foci of 1"- 
cell lymphocytes with myocyte necrosis ware present in 20 cases (67%). 
On the basis of the histopathol,~lic substrata, we obsowed a fatty (40%) 
and a fibrous-fa~' (60%) patterns. The fibrous-fatty pattern showed a higher 
inddence of ventdcuisr arrhythmias (p = 0.05), a thinner RV wall Co < 0.0001 ), 
and a higher occurrence of focal myocardifis, left veafficular involvement and 
RV aneurysms (p < 0.051). In conclusion, myocardial atrophy observed in 
the flbrous4atly vadaty of ARVC, appears to be the cons~quanca of an 
acquired injury (necrosis) and repair (fibrous-fatty replacement) progressive 
process, mediated by pato~, myscardifis; whether Inflammation is a pdmary 
event or reactive to spontaneous necrosis remains obscure. A programmed 
cell death or apoptosis in the seffing of poalnatal involution of the RV might 
be considered. 
~ Chagas' Heart Patiants Without Cardiac 
Enlargement Have impaired ElPiCardial Coronary 
Vasodliation but  No Vasotonl¢ Angina 
Marcus V. SimSes, Elias M. Ayms-Neto, J. L Attab-Santos, B. C. Maclel, J. 
A. Marin-Neto. University of S~o Paulo, Riboir~o Prsfo, Brazil 
Myocardial pallusicn defects are detected in many Chegas' heart patients 
(CHP) and coronary spasm has been postulated to cause these distur- 
bancas. In pts with vesotonic angina (VA), hypeweatilatton (H) provokes 
vasoconstriction responsive to nitrates. Aim of this study was to measure va- 
sometor epicam'fal coronary responses to H and IsesodMde dinifmte (ISDN), 
in 24 CHP (oge 56 ± 9,14 M), 15 with (D.CHP) and 9 without cardiac dilation 
(ND-CHP), and 9 VA pts w~h angiographycally normal ceroeary arteries (ege 
45 4- 9, 3 M). Quantitative asgiography was performed at baseline (B), after 
H, and after administration of 5 mg of ISDN, in proximal (LADP) and distal 
(LADD) segments of the left antedor descendibg comnmy artery and proxk 
mal segments of left clrcunflox artery (CXP). No pa'dents had clinical or EKG 
Ischen~ char~ns during H, and never was focal or d'dfose spasm detected. 
